ProShare Advisors’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-12,076
Closed -$7.46K 2132
2024
Q2
$7.46K Sell
12,076
-4,121
-25% -$3.48K ﹤0.01% 1839
2024
Q1
$41.6K Buy
16,197
+1,672
+12% +$4.08K ﹤0.01% 1929
2023
Q4
$29.6K Sell
14,525
-2,963
-17% -$5.41K ﹤0.01% 1900
2023
Q3
$30.1K Buy
17,488
+320
+2% +$568 ﹤0.01% 1761
2023
Q2
$33.5K Buy
+17,168
New +$40.2K ﹤0.01% 1809
2022
Q2
Sell
-15,041
Closed -$62K 2183
2022
Q1
$62K Sell
15,041
-3,871
-20% -$20.5K ﹤0.01% 2099
2021
Q4
$243K Buy
+18,912
New +$209K ﹤0.01% 1912
2021
Q3
Sell
-10,476
Closed -$96K 2310
2021
Q2
$96K Buy
+10,476
New +$96.9K ﹤0.01% 2297
2020
Q1
Sell
-11,121
Closed -$100K 1643
2019
Q4
$100K Buy
+11,121
New +$92.7K ﹤0.01% 1694

Other funds holding GRTS

ProShare Advisors's GRTS Position: Q3 2024 in Review

ProShare Advisors sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q3 2024, closing a stake of 12,076 shares — an estimated $7.46K sold.

ProShare Advisors first reported a position in GRTS in Q4 2019 and held it in 9 quarters. The position peaked at $243K in Q4 2021. 56 funds tracked by Wall St. Rank hold GRTS as of Q3 2024.

  • ProShare Advisors reported no remaining Gritstone bio, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • ProShare Advisors sold 12,076 Gritstone bio, Inc. Common Stock shares in Q3 2024, an estimated $7.46K.
  • ProShare Advisors first reported a position in Gritstone bio, Inc. Common Stock in Q4 2019 and held it in 9 quarters.
  • ProShare Advisors's Gritstone bio, Inc. Common Stock position peaked at $243K in Q4 2021.
  • 56 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q3 2024.

Based on ProShare Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.